Euromedgroup

Acquired By Dermapharm
Manufacturer of standardized herbal extracts and botanical active ingredients

About Euromedgroup

Euromedgroup is a Healthcare company, and was acquired by Dermapharm in January 2019. Manufacturer of standardized herbal extracts and botanical active ingredients. Its focus areas include Alternative Medicine Products. Its legal entity is Euromed S.A.

Company details

Standardized herbal extracts and botanical active ingredients are produced by Euromedgroup for pharmaceutical, nutraceutical, food, pet care, and cosmetic sectors. Botanical raw materials are sourced and processed under Good Agricultural and Collection Practices (GACP) guidelines, including organic standards. Extracts from Mediterranean fruits and vegetables are developed using water-based technology, alongside traditional botanicals. Emphasis is placed on research and development to deliver traceable, quality-controlled products meeting industry requirements.

Key Metrics

Investors in Euromedgroup

Euromedgroup has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Dermapharm and The Riverside Company.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity and debt are provided to middle market companies.
riversidecompany.comCleveland, United States
Dermatological and pharmaceutical medications are developed and manufactured.
1991dermapharm.deGrunwald, Germany
Premium access

Investor details for Euromedgroup

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Euromedgroup

2 dated milestones of Euromedgroup across 4 years, from founding to its latest funding, stage changes and deals.

  1. Exit Acquired by Riverside.
  2. Exit Acquired by Dermapharm.

Web traffic of Euromedgroup

The website of Euromedgroup (euromedgroup.com) receives about 3.7K visits a month.

  • Monthly visits
    3.7K

    ▲ 25.8% vs previous month

Similar websites

Websites whose visitors overlap most with Euromedgroup. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
bickfordflavors.com
bickfordflavors.com
100%
#2,043,377–
inolex.com
94%
7.9K#2,884,141View details
valleyfig.com
valleyfig.com
88%
#881,200–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Euromedgroup

Standardized herbal extracts and botanical active ingredients are produced by Euromedgroup for pharmaceutical, nutraceutical, food, pet care, and cosmetic sectors. Botanical raw materials are sourced and processed under Good Agricultural and Collection Practices (GACP) guidelines, including organic standards. Extracts from Mediterranean fruits and vegetables are developed using water-based technology, alongside traditional botanicals. Emphasis is placed on research and development to deliver traceable, quality-controlled products meeting industry requirements.

Euromedgroup has 2 investors. Key investors include Dermapharm, and The Riverside Company.

Euromedgroup operates through Euromed S.A..

Yes. Euromedgroup was acquired by Dermapharm in January 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available